Back to Search
DAVID HOLTZMAN, M.D., M.SC.
M.D., M.SC.
Infectious Disease Physician
NPI: 1184886764IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MT192540(PA)
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MT192540(PA)
CMS Specialties
PrimaryINFECTIOUS DISEASE
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 2008
Research & Publications (20)
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
PMID 19410600·Prev Med·2009
4-observational
Autistic spectrum disorders and mitochondrial encephalopathies.
PMID 18532934·Acta Paediatr·2008
8-other
Prospective case series on the effects of lumbosacral manipulation on dysmenorrhea.
PMID 18394502·J Manipulative Physiol Ther·2008
3-trial
Nutritional counseling in the chiropractic practice: a survey of New York practitioners.
PMID 19674691·J Chiropr Med·2007
8-other
In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.
PMID 15181253·J Mol Neurosci·2004
6-review
Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.
PMID 11816788·J Mol Neurosci·2001
6-review
Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
PMID 10852539·Ann Neurol·2000
7-preclinical
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
PMID 10694577·Proc Natl Acad Sci U S A·2000
7-preclinical
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease.
PMID 18762354·Neurobiol Aging·2010
7-preclinical
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
PMID 19581601·Proc Natl Acad Sci U S A·2009
7-preclinical
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.
PMID 19339619·J Neurosci·2009
7-preclinical
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.
PMID 19260027·Ann Neurol·2009
8-other
Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease.
PMID 19524672·Neurobiol Dis·2009
7-preclinical
Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses.
PMID 19624097·ACS Chem Biol·2009
7-preclinical
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.
PMID 19581723·J Alzheimers Dis·2009
7-preclinical
Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention.
PMID 19355934·CNS Neurol Disord Drug Targets·2009
6-review
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
PMID 19360898·Ann Neurol·2009
2-rct
Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.
PMID 19433664·Arch Neurol·2009
8-other
Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury.
PMID 19570023·ASN Neuro·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 801 MASSACHUSETTS AVE STE 2
BOSTON, MA 02118 - Phone
- (617) 414-7019
Quick Facts
- NPI
- 1184886764
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile